Neurodegenerative diseases such as Huntington’s or Parkinson’s disease are associated with misfolded and aggregated proteins. Researchers have discovered a new mechanism used by cells to protect themselves. Researchers have identified a protein complex that marks misfolded proteins, stops t ... more
Prof. Dr. Klaus Gerwert
Ruhr-Universität Bochum (RUB), Lehrstuhl für Biophysik
Klaus Gerwert studied physics in Münster and received his doctorate in 1985 in biophysical chemistry in Freiburg. After positions at the Max Planck Institute of Molecular Physiology in Dortmund and the Scripps Research Institute in La Jolla, USA, he accepted a university professorship in biophysics at Ruhr University Bochum in 1993. He is Fellow of the Max Planck Society since 2008, has been Director at the Max Planck Partner Institute for Computational Biology (PICB) in Shanghai, China, from 2008 to 2013. Gerwert actively promotes the development and application of vibrational spectroscopy in protein research, and is the holder of several patents. He is the founder and spokesperson of Collaborative Research Centre 642, “GTP- and ATP-dependent membrane processes” (2004–2016). In 2010, he founded the European “Protein Research Unit Ruhr within Europe” (PURE) together with clinicians. He is the founding director of ProDi, a federal/state-financed research centre for molecular protein diagnostics. Gerwert is a member of the North Rhine-Westphalian Academy of Sciences, Humanities and the Arts. His accolades include the Karl Arnold Jansen Prize from the North Rhine-Westphalian Academy of Sciences and the Ruhr Innovation Prize jointly awarded by the State Premier’s office and the Krupp Foundation.